Log in to save to my catalogue

Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Li...

Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Li...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2406942302

Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease

About this item

Full title

Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease

Publisher

United States: Wolters Kluwer

Journal title

The American journal of gastroenterology, 2020-08, Vol.115 (8), p.1289-1292

Language

English

Formats

Publication information

Publisher

United States: Wolters Kluwer

More information

Scope and Contents

Contents

We investigated the longitudinal impact of antinuclear antibody (ANA) on clinical outcomes and survival in nonalcoholic fatty liver disease (NAFLD).
ANA were found in 16.9% of 923 biopsy-proven NAFLD patients, but none of them had histologic autoimmune hepatitis (AIH) or developed AIH after a mean follow-up of 106±50 months.
Although ANA-posi...

Alternative Titles

Full title

Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2406942302

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2406942302

Other Identifiers

ISSN

0002-9270

E-ISSN

1572-0241

DOI

10.14309/ajg.0000000000000676

How to access this item